Skip to content

Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants

The Efficacy of Umbilical Cord Milking on the Reduction of Red Blood Cell Transfusion Rates in Infants Born Between 24 and 28 6/7 Weeks Gestation, a Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01523769
Enrollment
113
Registered
2012-02-01
Start date
2009-09-30
Completion date
2011-11-30
Last updated
2012-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prematurity

Keywords

prematurity, umbilical cord milking, delayed cord clamping, neonatal transfusion

Brief summary

Delayed cord clamp of at least 30 seconds in neonates under 37 weeks has shown that these infants have higher circulating blood volume in the first 24 hours, less need for blood transfusions, and less incidence of intraventricular hemorrhage. Delayed umbilical cord clamping has also been shown to increase the initial hematocrit and decrease the need for red blood cell (RBC) transfusions compared with no intervention in infants born between 27 and 33 weeks' gestation. However, a delay in cord clamping of 30-45 seconds may theoretically interfere with neonatal resuscitation. There have been few studies that addressed the active milking of the cord and its effect on neonatal resuscitation. Active milking of the umbilical cord towards the baby prior to clamping (rather than passive) should take less than 5 seconds to perform and should not interfere with neonatal resuscitation. Umbilical cord milking, as an alternative to delayed cord clamping, has been shown to increase the circulatory blood volume expressed as the hemoglobin value. Active milking of the cord prior to clamping, however, is not considered standard of care and only 1 Japanese randomized control study has reported that umbilical cord milking reduces the need for RBC transfusions, thus reducing the number of infants requiring a RBC transfusion as compared with control conditions. Our study aims to test the hypothesis that active milking of the umbilical cord will reduce the need for transfusion in preterm infants.

Detailed description

The proposed design is a randomized controlled trial. Pregnant women at risk for delivering a singleton preterm infant between 24 and 28 weeks gestation will be randomized prior to delivery into one of two treatment arms. Common reasons for needing to be delivered at this early gestational age include but are not limited to: preterm labor not responding to tocolytic medications, incompetent cervix with cervical dilation and no contractions, clinical chorioamnionitis requiring delivery for maternal/fetal benefit, severe preeclampsia, severe growth restriction with a non-reassuring fetal heart rate tracing. The first arm will include active milking of the umbilical cord toward the neonate's umbilicus prior to cord clamping at delivery while the second arm will not include this intervention and will have their respective cord immediately clamped in the usual fashion post delivery (control).

Interventions

PROCEDUREUmbilical Cord Milking

Approximately 10 cm of umbilical cord was milked toward the baby immediately following delivery. (The blood remaining in the umbilical cord after delivery is squeezed in the direction from the placenta (remaining inside the uterus) toward the newborn baby.)

Sponsors

Eastern Virginia Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Singleton pregnancy * Delivery anticipated between 24 and 28+6 weeks gestation * There is enough time from admission to anticipated delivery to properly obtain consent from the patient

Exclusion criteria

* Multifetal gestation * Antenatally diagnosed major congenital anomaly * Known Rh sensitized pregnancy * Hydrops fetalis (any etiology) * Known positive maternal Parvovirus titers * Elevated peak systolic velocity of the fetal Middle Cerebral Artery (MCA) * Clinical suspicion of placental abruption at delivery due to excessive maternal bleeding or uterine hypertonicity * Maternal age under 18

Design outcomes

Primary

MeasureTime frameDescription
Red blood cell transfusion28 daysneed for packed red blood cell transfusion in the first 28 days of neonatal life

Secondary

MeasureTime frameDescription
Intraventricular Hemorrhage28 daysdiagnosis of IVH in first 28 days of neonatal life
Days until transfusion28 daysnumber of days until first RBC transfusion in first 28 days of life
Respiratory Distress Syndrome28 daysdiagnosis of RDS in first 28 days of neonatal life
Retinopathy of Prematurity28 daysdiagnosis of ROP in first 28 days of neonatal life
Chronic Lung Disease28 daysdiagnosis of CLD in first 28 days of neonatal life
Sepsis28 daysdiagnosis of sepsis in first 28 days of neonatal life
Necrotizing Enterocolitis28 daysdiagnosis of nec in first 28 days of neonatal life
Apgar scores10 minutes1, 5, and 10 minute Apgars scores
cord PH1 hourumbilical cord pH immediately after delivery
Volume of blood transfusion28 daystotal volume of packed RBC's transfused in first 28 days of neonatal life
Initial Hemoglobin/Hematocrit1 dayInitial neonatal H/H
Initial blood pressure1 dayInitial neonatal blood pressure
Neonatal jaundice28 daysNeed for bili lights to treat neonatal jaundice, maximum total bilirubin, number of days of bili lights
Neonatal death28 daysIncidence of neonatal death in the first 28 days of life, age of neonate at death
Length of admission28 daysLength of neonatal admission (up to 28 days)
Length of intubation28 daysLength of need for neonatal intubation in first 28 days of life
Periventricular Leukomalacia28 daysdiagnosis of PVL in first 28 days of neonatal life
Hyperkalemia28 daysdiagnosis of Hyperkalemia in first 28 days of neonatal life
Neonatal resuscitation1 hourNeonatal Resuscitation measures immediately after birth, including intubation, surfactant administration, stimulation, compressions, epinephrine

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026